Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems

Atomoxetine is a selective noradrenaline reuptake inhibitor drug. Based on the knowledge that agents increasing monoamine levels in the central nervous system have therapeutic potential for neuropathic pain, it is planned to investigate the possible efficacy of atomoxetine on diabetes-induced hypera...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbaros, Mustafa Burak, Can, Özgür Devrim, Üçel, Umut İrfan, Turan Yücel, Nazlı, Demir Özkay, Ümide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222656/
https://www.ncbi.nlm.nih.gov/pubmed/30126223
http://dx.doi.org/10.3390/molecules23082072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222656/
https://www.ncbi.nlm.nih.gov/pubmed/30126223
http://dx.doi.org/10.3390/molecules23082072

Ejemplares similares